Novus Therapeutics Inc (NVUS) stock is down -18.6% Thursday and is lower by -88.97% over the last 12 months. The average rating from Wall Street analysts is a Strong Buy. Stock Score Report, InvestorsObserver’s proprietary scoring system, gives NVUS stock a score of 31 out of a possible 100.
That score is mainly influenced by a short-term technical score of 1. NVUS's score also includes a long-term technical score of 3. The fundamental score for NVUS is 88. In addition to the average rating from Wall Street analysts, NVUS stock has a mean target price of $10.00. This means analysts expect the stock to gain 1983.33% over the next 12 months.
Click Here to get the full Stock Score Report on Novus Therapeutics Inc (NVUS).
What's Happening with NVUS Stock Today
Novus Therapeutics Inc (NVUS) stock is lower by -18.72% while the S&P 500 has gained 0.27% as of 11:26 AM on Thursday, Oct 17. NVUS is lower by -$0.11 from the previous closing price of $0.59 on volume of 303,821 shares. Over the past year the S&P 500 is up 6.69% while NVUS is lower by -88.97%. NVUS lost -$1.56 per share in the over the last 12 months.
